Tuesday, June 07, 2022 8:47:30 AM
Cathy Scangarella to Join the Advisory Board of Xcelerate, Inc.
Mauldin, SC., June 7, 2022 --Xcelerate, Inc. (OTC Markets: "XCRT”) today announced that Cathy
Scangarella has accepted an invitation to join its Advisory Board effective immediately.
Cathy Scangarella is the Chief Business Development Officer and sector lead for Life Sciences at
Choose New Jersey, New Jersey’s leading nonprofit economic development organization. Cathy
leads the business development team and oversees the organization’s national and international
lead generation, prospect management and business development strategy for all key industries.
She also oversees the Choose New Jersey India and Europe offices and has enhanced New
Jersey’s relationships with key multipliers and trade associations around the globe.
During her tenure at Choose New Jersey, Cathy developed a new tactical business development
approach for business attraction efforts to concentrate efforts in key domestic and international
markets. She had a leading role in the strategic planning of Choose New Jersey’s business
attraction missions to Israel, Germany, Ireland, and India. While abroad, she helped established
international university collaborations and industry partnerships for many of New Jersey’s
research universities including Rutgers University, Princeton University, New Jersey City
University and Rowan University. Notable clients include Ascelia Pharma, BAP Pharma, CSL
Plasma, Fordoz Pharmaceuticals, Minerva Biolabs and Biofarma US.
Cathy is a veteran of New Jersey State government, having served six administrations. With over
25 years of experience in marketing, outreach, and business development, she has served as
Deputy Chief of Staff to Lt. Governor Guadagno, Director of State Marketing at the New Jersey
Business Action Center, Director of Outreach Programs for Business Retention & Attraction at the
New Jersey Economic Development Authority, and Vice President of Marketing &
Communications for the New Jersey Commerce Commission. Cathy is a member of the Research
With New Jersey Advisory Board, the Innovation New Jersey Coalition, and an E&Y Entrepreneur
of the Year Judge 2019-2021. She was named among the ROI-NJ Influencers: Women in Business
– Economic Development in 2021.
Cathy holds a Bachelor of Science degree in Business Administration with a concentration in
Marketing from Ramapo College of New Jersey.
“Cathy brings a valued new skill set to our Advisory Board,” said Michael O’Shea, Xcelerate’s CEO.
“Cathy’s’ experience business development, along with her years of relationships with research
institutions, should prove invaluable to Xcelerate as we begin to advance the development of the
portfolio of patents recently acquired from HS Pharmaceuticals as well as our continued
development of patentable med-tech. ”
Recent XCRT News
- Form 1-SA - • Edgar (US Regulatory) • 09/24/2024 05:37:58 PM
- Form 1-U - Current Report Pursuant to Regulation A • Edgar (US Regulatory) • 05/10/2024 07:01:28 PM
- Form 1-U - Current Report Pursuant to Regulation A • Edgar (US Regulatory) • 05/06/2024 03:55:15 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM